Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda: preliminary findings from the ALTER trial (S25.003).

Neurology

Freddie Kibengo, Anita Kabarambi, Paddy Kafeero, Patrick Muhumuza, Maria Nakimbugwe, Anthony Ssemaganda, Colman Tayebwa, Payam Nahid, Fiona Cresswell, Felicia Chow. Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda: preliminary findings from the ALTER trial (S25.003). Neurology. 2023 Apr 25; 100(17_supplement_2).

2023

https://researcherprofiles.org/profile/593758847

Freddie Kibengo, Anita Kabarambi, Paddy Kafeero, Patrick Muhumuza, Maria Nakimbugwe, Anthony Ssemaganda, Colman Tayebwa, Payam Nahid, Fiona Cresswell, Felicia Chow

Search form

You are here

Safety and tolerability of adjunctive linezolid with high or standard dose rifampin for the treatment of adults with HIV-associated tuberculous meningitis in Uganda: preliminary findings from the ALTER trial (S25.003).